Evidence mapPaperPMID 23720336Full record

ReviewComprehensive Physiology2013

Immune and inflammatory role in renal disease.

John D Imig, Michael J Ryan

Abstract readReview
In one paragraph

Review in Comprehensive Physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 189 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
189citing papers in PubMed, 3 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

189 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Cytokine storm in acute respiratory distress syndrome.Journal of intensive medicine · 2026
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Observational
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Review

129 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

John D ImigDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. jdimig@mcw.edu
Michael J Ryan

Funding

TRANSPORT EFFECTS OF ARACHIDONATE METABOLITES IN PERFUSED TUBULEP01DK038226 · VANDERBILT UNIVERSITY · 1986 to 2005
$8.5M
OXYGENASE METABOLITES AND RENAL VASCULAR ACTIVITYR01HL059699 · TULANE UNIVERSITY OF LOUISIANA · 1999 to 2005
$1.4M
MODELS FOR HEME PROTEIN BIOCHEMISTRY AND SPECTROSCOPYR01DK038826 · GEORGIA STATE UNIVERSITY · 1986 to 1987
OXYGENASE METABOLITES AND RENAL VASCULAR ACTIVITYR29HL059699 · TULANE UNIVERSITY OF LOUISIANA · 1998 to 1998
NHLBI NIH HHS HL-085907NHLBI NIH HHS HL-092284NHLBI NIH HHS HL-59699NHLBI NIH HHS K02 HL092284NHLBI NIH HHS R01 HL059699NHLBI NIH HHS R01 HL085907NIDDK NIH HHS DK38826NIDDK NIH HHS P01 DK038226
6 · The paper itself

Abstract

Chronic and acute renal diseases, irrespective of the initiating cause, have inflammation and immune system activation as a common underlying mechanism. The purpose of this review is to provide a broad overview of immune cells and inflammatory proteins that contribute to the pathogenesis of renal disease, and to discuss some of the physiological changes that occur in the kidney as a result of immune system activation. An overview of common forms of acute and chronic renal disease is provided, followed by a discussion of common therapies that have anti-inflammatory or immunosuppressive effects in the treatment of renal disease.

Indexed as

AnimalsAnti-Inflammatory AgentsHumansImmunity, InnateImmunologic FactorsInflammationKidney DiseasesAnti-Inflammatory AgentsImmunologic Factors

Identifiers

PMID23720336
PMCPMC3803162

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.